ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Impact of Tacrolimus Formulation on Tacrolimus Level Coefficient of Variations

    S. January1, T. Horwedel2, J. Hagopian1, C. Carthon1, A. Gharabagi3, R. Delos Santos4

    1Barnes-Jewish Hospital, Saint Louis, MO, 2Veloxis Pharmaceuticals, Inc., Cary, NC, 3Saint Louis College of Pharmacy, Saint Louis, MO, 4Washington University School of Medicine, Saint Louis, MO

    *Purpose: Increased coefficient of variation (CV) of tacrolimus (FK) levels, indicating high intra-patient FK level fluctuations, are associated with increased rejection, development of donor-specific antibodies,…
  • 2019 American Transplant Congress

    Outcomes for Liver Transplant Recipients on Renal Replacement Therapy: Who Cannot Wait for Safety Net

    A. Pita1, N. Kaur1, M. Lo2, A. F. Sabour1, V. Tristan1, Y. Genyk1, M. K. Nadim3, L. Sher1

    1Department of Surgery, Keck Medical Center of USC, Los Angeles, CA, 2Department of Preventive Medicine, Keck Medical Center of USC, Los Angeles, CA, 3Department of Medicine, Keck Medical Center of USC, Los Angeles, CA

    *Purpose: The purpose of this study is to identify risk factors for poor outcomes for liver transplant (LT) recipients on renal replacement therapy (RRT) in…
  • 2019 American Transplant Congress

    Early Achievement of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Reduces Risks of End Stage Renal Disease

    M. Yoshikawa1, T. Fukumoto2

    1Nephrology, Kobe University Hospital, Kobe, Japan, 2Hepato-Biliary-Pancreas Surgery, Kobe University Hospital, Kobe, Japan

    *Purpose: Chronic kidney disease (CKD) is common after liver transplantation (LT) and result worse morbidity and mortality. Hepatitis C virus (HCV) infection is recognized as…
  • 2019 American Transplant Congress

    Outcomes of Side-to-Side Cavocavostomy versus Traditional Piggyback Implantation in Liver Transplantation

    T. Lee, V. Dhar, M. Morris, L. Winer, A. Cortez, L. Sage Silski, M. Cuffy, T. Diwan, R. Quillin, III, S. Shah

    University of Cincinnati, Cincinnati, OH

    *Purpose: Side-to-side cavocavostomy (STSCC) is an alternative caval sparing implantation technique for liver transplantation (LT), but despite its technical ease compared to traditional piggyback (TP)…
  • 2019 American Transplant Congress

    Incidence of Cytomegalovirus in Moderate Risk Kidney Transplant Recipients Receiving Low Dose Valganciclovir

    T. Fallah1, A. Logan2, L. Beltran Garcia3, L. Bowman2

    1Hospital of the University of Pennsylvania, Philadelphia, PA, 2Tampa General Hospital, Tampa, FL, 3Florida Kidney Physicians, Tampa General Hospital, Tampa, FL

    *Purpose: Studies evaluating the efficacy of valganciclovir (VGC) at 450 mg daily versus 900 mg daily for the prevention of cytomegalovirus (CMV) in kidney transplant…
  • 2019 American Transplant Congress

    Outbreak of Pneumocystis Pneumonia in a Transplant Center Linked to a Single Genotype of Pneumocystis jirovecii: Effects of Cytomegalovirus Infection and Allograft Rejection

    S. Hosseini-Moghaddam1, S. Dufresne2, M. Shokoohi3, G. Singh1, E. HunterGutierrez1, P. Dufresne2, A. House1, P. Luke1, A. Nagpal1, P. Marotta1, A. Humar4, A. Jevnikar1, D. Kumar4

    1Western University,LHSC,University Hospital, London, ON, Canada, 2Maisonneuve-Rosemont Hospital,Université de Montréal, Montreal, QC, Canada, 3Epidemiology and Biostatistics, Western University, London, ON, Canada, 4University of Toronto, University Health Network, Toronto General Hospital, Toronto, ON, Canada

    *Purpose: Although post-transplant pneumocystis pneumonia (PCP) outbreaks have been reported from Asia, Australia and Europe, there are limited data from North America. We investigated transmissibility…
  • 2019 American Transplant Congress

    Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period

    S. Sarwar, S. Gleeson, M. Malinis, M. M. Azar

    Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT

    *Purpose: Antibiotic prophylaxis for enteric pathogens is recommended before liver transplantation (LT). Perioperative screening protocols and antimicrobials vary between institutions. Some institutions that do not…
  • 2019 American Transplant Congress

    Effects of Omega-3 Fatty Acids on Outcome after Living Donor Right Hepatectomy

    S. Lee, J. Kim, G. Choi, J. Joh, S. Lee

    Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Preclinical data suggest that supplementation of omega-3 fatty acids may be beneficial in liver resections, by ameliorating ischemic injury during the surgical procedure. In…
  • 2019 American Transplant Congress

    Estrogen Mediated Protection in Renal Ischemia Reperfusion Injury (IRI) is Extrinsic to the Kidney

    D. D. Aufhauser1, S. J. Concors1, P. T. Hernandez1, Z. Wang1, L. Krumeich1, D. R. Murken1, G. Ge1, W. W. Hancock2, M. H. Levine1

    1Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 2Pathology, Children's Hospital of Philadelphia, Philadelphia, PA

    *Purpose: IRI causes morbidity in renal transplantation and other surgical scenarios. A better understanding of the molecular mechanisms of IRI is required so that strategies…
  • 2019 American Transplant Congress

    A Prognostic Drug Development Tool to Assess the Transplantability at the Time of Listing for Kidney Transplant Candidates

    S. Kawakita1, L. Hidalgo-Semlek2, J. L. Beaumont1, J. Lee2, M. J. Everly1

    1Terasaki Research Institute, Los Angeles, CA, 2Hansa Medical AB, Lund, Sweden

    *Purpose: At time of listing for kidney transplant (KT), a patient is not informed of the probabilities of KT, death, or remaining on the waiting…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences